These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Prophylaxis of thromboembolism during therapy with asparaginase in adults with acute lymphoblastic leukaemia. Rank CU; Lynggaard LS; Als-Nielsen B; Stock W; Toft N; Nielsen OJ; Frandsen TL; Tuckuviene R; Schmiegelow K Cochrane Database Syst Rev; 2020 Oct; 10(10):CD013399. PubMed ID: 33038027 [TBL] [Abstract][Full Text] [Related]
26. Peroxisome proliferator-activated receptor gamma agonists for preventing recurrent stroke and other vascular events in patients with stroke or transient ischaemic attack. Liu J; Wang LN Cochrane Database Syst Rev; 2014 Jan; (1):CD010693. PubMed ID: 24399670 [TBL] [Abstract][Full Text] [Related]
27. Antithrombotic Treatment for Cervical Artery Dissection: A Systematic Review and Individual Patient Data Meta-Analysis. Kaufmann JE; Harshfield EL; Gensicke H; Wegener S; Michel P; Kägi G; Nedeltchev K; Kellert L; Rosenbaum S; Nolte CH; Christensen H; Arnold M; Lyrer P; Levi C; Bath PM; Engelter ST; Traenka C; Markus HS; JAMA Neurol; 2024 Jun; 81(6):630-637. PubMed ID: 38739383 [TBL] [Abstract][Full Text] [Related]
28. Percutaneous transluminal angioplasty and stenting for carotid artery stenosis. Coward LJ; Featherstone RL; Brown MM Cochrane Database Syst Rev; 2004; (2):CD000515. PubMed ID: 15106153 [TBL] [Abstract][Full Text] [Related]
29. Peroxisome proliferator-activated receptor gamma agonists for preventing recurrent stroke and other vascular events in patients with stroke or transient ischaemic attack. Liu J; Wang LN Cochrane Database Syst Rev; 2015 Oct; (10):CD010693. PubMed ID: 26511368 [TBL] [Abstract][Full Text] [Related]
30. Interventions for dysarthria due to stroke and other adult-acquired, non-progressive brain injury. Mitchell C; Bowen A; Tyson S; Butterfint Z; Conroy P Cochrane Database Syst Rev; 2017 Jan; 1(1):CD002088. PubMed ID: 28121021 [TBL] [Abstract][Full Text] [Related]
31. Antiplatelet versus anticoagulation treatment for patients with heart failure in sinus rhythm. Shantsila E; Lip GY Cochrane Database Syst Rev; 2016 Sep; 9(9):CD003333. PubMed ID: 27629776 [TBL] [Abstract][Full Text] [Related]
36. Antiplatelet and anticoagulant agents for secondary prevention of stroke and other thromboembolic events in people with antiphospholipid syndrome. Bala MM; Celinska-Lowenhoff M; Szot W; Padjas A; Kaczmarczyk M; Swierz MJ; Undas A Cochrane Database Syst Rev; 2020 Oct; 10(10):CD012169. PubMed ID: 33045766 [TBL] [Abstract][Full Text] [Related]
37. Remote ischaemic conditioning for preventing and treating ischaemic stroke. Zhao W; Zhang J; Sadowsky MG; Meng R; Ding Y; Ji X Cochrane Database Syst Rev; 2018 Jul; 7(7):CD012503. PubMed ID: 29974450 [TBL] [Abstract][Full Text] [Related]
38. Oral anticoagulants versus antiplatelet therapy for preventing further vascular events after transient ischaemic attack or minor stroke of presumed arterial origin. Algra A; de Schryver EL; van Gijn J; Kappelle LJ; Koudstaal PJ Cochrane Database Syst Rev; 2001; (4):CD001342. PubMed ID: 11687110 [TBL] [Abstract][Full Text] [Related]
39. Interventions for treating brain arteriovenous malformations in adults. Zuurbier SM; Al-Shahi Salman R Cochrane Database Syst Rev; 2019 Sep; 9(9):CD003436. PubMed ID: 31503327 [TBL] [Abstract][Full Text] [Related]